NCT04990882View on ClinicalTrials.gov

FAPI PET/CT Prospective Interobserver Agreement

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

October 30, 2022

Study Completion Date

October 30, 2022

Conditions
Malignant Neoplasm
Interventions
OTHER

Interpretation of FAPI-PET/CT scans

Each observer's Group will be asked to review FAPI-PET/CT scans of patients with representative cancer types.

Trial Locations (1)

Unknown

Department of Nuclear Medicine, Essen

All Listed Sponsors
lead

University Hospital, Essen

OTHER

NCT04990882 - FAPI PET/CT Prospective Interobserver Agreement | Biotech Hunter | Biotech Hunter